HSP90AA1 and hepatocellular carcinoma: Beyond that, the difference is that in this study, plasma HSP90α levels were assessed in secondary hepatic carcinoma cohorts, ant the results showed that the plasma HSP90α levels were also significantly higher in both an HCC cohort and a SHC cohort compared to patients with hemangioma, respectively.